The Clinical and Regulatory Operations team at Assembly Biosciences is responsible for overseeing the clinical trials and ensuring regulatory compliance to advance the development of innovative HBV therapies. This includes planning and executing clinical studies, managing trial sites, ensuring data integrity, and liaising with regulatory authorities to secure approvals for next-generation core inhibitors and combination therapies.
View all